Aurobindo Pharma signs pact with MSD to supply biologicals, to invest Rs.1000 crore on plant

Aurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, has signed a master service agreement with Merck Sharpe & Dohme Singapore for contract manufacturing of biologicals. The agreement, effective May 31, 2024, will see TheraNym contract manufacturing biologicals for domestic and international markets. TheraNym will invest Rs 1,000 crore in a biologics manufacturing facility in Telangana.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0h8AFJN
via IFTTT